Tirzepatide emerges a groundbreaking treatment agent for individuals facing type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://mattieehyl938737.glifeblog.com/39254886/tirzepatide-a-game-changer-for-type-2-diabetes